The ongoing personalized medicine revolution drives social and operational impact while improving therapy outcomes and patient satisfaction. Whereas the real-world implementation of artificial intelligence (AI) in medical oncology is advancing well, very few cancer...
A recent publication (Yurttas et al, PMID: 30572653) illustrated the dilemma of the empirical HIPEC protocols: only for colorectal cancer, 62 different chemotherapy protocols were published, making a comparison of data challenging. So far, only a handful of PIPAC...
According to ISSPP statutes, the ExCo has nominated Prof. Laurent Villeneuve as a new member, with the function of the Vice-President. Laurent has a Ph.D. in Public Health from University Lyon, a Master in biomedical engineering and is a certified Clinical...
ISSPP is proud to announce that the first collaborative publication of ISSPP researchers has been published online. A standardized survey with 82 closed-ended questions was sent online to active PIPAC centers. The survey inquired about center demographics (n = 8),...
ISSPP is proud to announce the launch of the new International Pressurized Intra. Peritoneal Aerosol Chemotherapy registry, which is accessible to all members of the society. Anonymized data from patients from all over the world will be entered into the database,...
